Market Place
Sourcing Support
All News #Library
Biotech
ADARx Pharma Presents Onvuzosiran Data for HAE Treatment
27 Feb 2026 //
GLOBENEWSWIRE
ADARx Reports Positive Interim Ph1 Data For siRNA Targeting CFB
07 Nov 2025 //
GLOBENEWSWIRE
ADARx Doses 1st Ph3 STOP-HAE Patient, Gets Orphan Tag for ADX-324
22 Oct 2025 //
GLOBENEWSWIRE
Adarx Pharma Presents Clinical Data At ASN Kidney Week 2025
20 Oct 2025 //
GLOBENEWSWIRE
Adarx Pharma Names Laura Shawver, Ph.D., Board Chair
17 Sep 2025 //
GLOBENEWSWIRE
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal
15 May 2025 //
PRESS RELEASE
ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer
30 Jul 2024 //
GLOBENEWSWIRE
ADARx preps 3rd clinical program and mulls IPO
03 Oct 2023 //
FIERCE BIOTECH
RNA biotech ADARx hauls in healthy $200M series C
09 Aug 2023 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.